Get the Stockscreener App
2.43
1.62%
-0.04
After Hours:
2.49
0.06
+2.47%
Bioxcel Therapeutics Inc Stock (BTAI) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
54.79%
0.582
|
0.376 | 0.341 | 0.457 | 0.206 |
| Cost Of Revenue |
88.80%
0.08
|
0.714 | 0.512 | 0.026 | 0.009 |
| Gross Profit |
248.52%
0.502
|
-0.338 | -0.171 | 0.431 | 0.197 |
Operating Expenses
|
26.25%
24.66
|
19.54 | 48.13 | 52.84 | 51.40 |
| Interest Income/Expense |
5.01%
3.607
|
3.435 | 3.252 | 3.259 | 3.367 |
| Benefits Costs and Expenses |
20.95%
27.37
|
22.63 | 48.64 | 52.87 | 53.00 |
| Costs And Expenses |
22.19%
24.75
|
20.25 | 48.64 | 52.87 | 51.40 |
| Operating Income/Loss |
21.57%
-24.16
|
-19.88 | -48.30 | -52.41 | -51.20 |
| Income/Loss From Continuing Operations Before Tax |
20.38%
-26.79
|
-22.26 | -48.30 | -53.52 | -52.80 |
| Income/Loss From Continuing Operations After Tax |
20.38%
-26.79
|
-22.26 | -50.49 | -53.52 | -52.80 |
|
Net Income/Loss
|
20.38%
-26.79
|
-22.26 | -50.49 | -53.52 | -52.80 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
29,869%
30.87
|
0.103 | 29.27 | 29.19 | 28.62 |
| Diluted Average Shares |
29,869%
30.87
|
0.103 | 29.27 | 29.19 | 0.0286 |
| Basic Earnings Per Share |
16.00%
-0.87
|
-0.75 | -1.72 | -1.83 | -1.84 |
| Diluted Earnings Per Share |
16.00%
-0.87
|
-0.75 | -1.72 | -1.83 | -1.84 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):